XML 23 R3.htm IDEA: XBRL DOCUMENT v3.26.1
Consolidated Statements of Operations - USD ($)
shares in Thousands, $ in Thousands
 12 Months Ended
Jan. 25, 2026
Jan. 26, 2025
Jan. 28, 2024
Total net sales $ 1,049,975 $ 909,287 $ 868,758
Amortization of acquired technology 9,193 9,106 33,716
Acquired technology impairments 0 0 91,792
Total cost of sales 507,831 452,759 572,508
Gross profit 542,144 456,528 296,250
Operating expenses, net:      
Product development and engineering 196,348 170,908 186,450
Selling, general and administrative 221,852 222,368 220,220
Intangible amortization 631 884 14,913
Restructuring 4,186 4,944 23,775
Intangible impairment 1,777 0 39,593
Impairment of goodwill 84,785 7,490 755,621
Total operating expenses, net 509,579 406,594 1,240,572
Operating income (loss) 32,565 49,934 (944,322)
Interest expense (40,618) (90,067) (95,813)
Interest income 2,522 2,302 3,051
Loss on extinguishment of debt 0 (144,688) 0
Non-operating (expense) income, net (5,262) 267 (542)
Investment impairments and credit loss reserves, net (10,387) (1,109) (3,929)
Loss before taxes and equity method income (loss) (21,180) (183,361) (1,041,555)
Provision (benefit) for income taxes 19,832 (22,012) 50,519
Net loss before equity method income (loss) (41,012) (161,349) (1,092,074)
Equity method income (loss) 636 (547) 45
Net loss (40,376) (161,896) (1,092,029)
Net income attributable to noncontrolling interest 0 0 1
Net loss attributable to common stockholders $ (40,376) $ (161,896) $ (1,092,030)
Loss per share:      
Basic (in dollars per share) $ (0.46) $ (2.26) $ (17.03)
Diluted (in dollars per share) $ (0.46) $ (2.26) $ (17.03)
Weighted average number of shares used in computing loss per share:      
Basic (in shares) 88,374 71,606 64,127
Diluted (in shares) 88,374 71,606 64,127
Products      
Total net sales $ 942,087 $ 794,379 $ 754,018
Cost of sales: 448,642 394,268 393,971
Services      
Total net sales 107,888 114,908 114,740
Cost of sales: $ 49,996 $ 49,385 $ 53,029